An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) ...

Hope Therapeutics, a wholly-owned subsidiary of NRx Pharmaceuticals (NRXP), announced engagement of BTIG, a leading global financial services firm specializing in investment banking, institutional ...

HOPE has announced plans to assemble a best-in-class global network of interventional psychiatry clinics combining ketamine treatment with transcranial magnetic stimulation, and digital ...

Print copy of The Tablet delivered directly to your door. Complete access to all Tablet website content including all premium content. Access to the weekly digital copy of The Tablet.

Easy enough. General purpose tablets aren't a bad choice at all — many sites name the iPad as one of the best tablets for kids even though it's technically for everyone. The most important ...

Apple’s iPads have long been the gold standard in the tablet industry ... and even access files from an iPhone, all without any manual transfers. Apple’s design philosophy emphasizes both ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...

If you want space savings, power, and flexibility—all from a single desktop computer—you need an all-in-one (AIO) PC. Our guide of fully tested products will help you shop for one of these ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...